已收盘 08-01 16:00:00 美东时间
-1.120
-6.79%
InspireMD聘请Raymond W. Cohen为董事会成员,其拥有40年以上医疗科技领导经验,曾成功推动Axonics以37亿美元被Boston Scientific收购。InspireMD近期获FDA批准,即将推出CGuard Prime钴基颈动脉支架系统,Cohen的加入将助力公司加速商业化进程并提升长期价值。
07-31 12:31
Kestra Medical Technologies, Ltd. has been named a 2025 Top Workplaces Industry winner by Energage, recognizing its people-first workplace culture in the healthcare sector. The award, based on employee feedback, highlights Kestra's strong culture and commitment to empowering its team to improve patient outcomes. Brian Webster, CEO, emphasizes that this recognition validates their culture's effectiveness in advancing cardiac care.
07-17 12:00
Kestra Medical Technologies shares are trading lower following worse-than-expec...
07-17 03:02
Kestra Medical Technologies Ltd. ( ($KMTS) ) has released its Q4 earnings. Here...
07-16 11:57
Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $85.000M vs $82.972M Est
07-16 04:08
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(2.21) per share which missed the analyst consensus estimate of $(0.56) by 294.64 percent. The company reported quarterly sales of $17.233 million which
07-16 04:05
Companies Reporting Before The Bell • Telefonaktiebolaget L M (NASDAQ:ERIC) is ...
07-15 16:32
Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) announced it will release its fourth quarter and fiscal year 2025 financial results on July 15, 2025. A conference call will be held at 4:30 p.m. Eastern Time, with a live and archived webcast available on the company’s investor relations website. The company, focused on wearable medical devices for cardiovascular disease, aims to improve patient outcomes through innovative technologies. For more i...
07-01 12:00
Kestra Medical Technologies, Ltd. has been added to the Russell 3000® Index and the Russell 2000® Index, effective June 27. The inclusion follows the annual reconstitution of Russell indexes, which ranks the 4,000 largest U.S. stocks by market cap. Russell indexes are widely used by investors, with $10.6 trillion in assets benchmarked against them. Kestra’s CEO, Brian Webster, stated that this milestone reflects the company’s progress since its M...
06-23 12:00
Kestra Medical Technologies, Ltd. has appointed Conor Hanley as an independent director, effective June 4, 2025. Brian Webster, President and CEO, expressed his excitement about Hanley's deep expertise in medical technology and cardiac care, which will support the growth of the ASSURE® system. Hanley brings extensive experience from his roles as CEO of FIRE1, a venture-backed medical device company, and leadership positions at ResMed and BiancaMe...
06-05 12:00